Home LiteratureArticle Details
PMID: 11062791 Published · ppublish English Journal Article

Sertraline treatment of interferon-alfa-induced depressive disorder.

The Medical journal of Australia ·Vol. 173 ·No. 7 ·2000-10-02 ·Pages 359-61

Schramm TM, Lawford BR, Macdonald GA, Cooksley WG

Abstract

Interferon alfa therapy for chronic hepatitis C infection is commonly associated with neuropsychiatric symptoms, including depression. These side effects may necessitate reduction or even cessation of interferon alfa, but there is little information regarding the management of this important problem. We report 10 cases of interferon-alfa-induced depressive disorder treated with the selective serotonin reuptake inhibitor sertraline. All patients obtained rapid symptom relief without the need for reduction or cessation of interferon alfa.

MeSH Terms
Adult Depressive Disorder/chemically induced,drug therapy Female Hepatitis C/drug therapy Humans Interferon-alpha/adverse effects Irritable Mood Male Middle Aged Serotonin Uptake Inhibitors/adverse effects,therapeutic use Sertraline/adverse effects,therapeutic use
Chemicals
Interferon-alpha Serotonin Uptake Inhibitors Sertraline
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Schramm T M
Mental Health Centre, Royal Brisbane Hospital, Herston, QLD. [email protected]
Lawford B R
Macdonald G A
Cooksley W G
Article Info
Journal
The Medical journal of Australia
Abbr.
Med J Aust
ISSN
0025-729X
Published
2000-10-02
Pages
359-61
Language
English
Region
Australia
NLM ID
0400714
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]